Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants
Keyword(s):
SARS-CoV-2 is the most recently identified member of the betacoronavirus genus responsible for the COVID-19 pandemic. Repurposing of available drugs has been a “quick and dirty” approach to try to reduce mortality and severe symptoms in affected patients initially, and can still represent an undeniable and valuable approach to face COVID-19 as the continuous appearance and rapid diffusion of more “aggressive”/transmissible variants, capable of eluding antibody neutralization, challenges the effectiveness of some anti-SARS-CoV-2 vaccines.
2014 ◽
Vol 63
(1)
◽
pp. 53-63
◽
Keyword(s):
2008 ◽
Vol 89
(11)
◽
pp. 2709-2712
◽
2019 ◽
Vol 48
(5)
◽
pp. 533-548
◽
1989 ◽
Vol 47
(2)
◽
pp. 343-347
◽
1999 ◽
Vol 29
(1)
◽
pp. 291-299
◽
2016 ◽
Vol 13
(6)
◽
pp. 750-755
◽